Indices
NEIMETH
| Price | Today's Change | Avg daily Volume | 1 Year Change | 52 Week Range |
|---|---|---|---|---|
| 2.78 | 0.00 (0.00%) | 913.65K | 0.80 (40.40%) | 1.51 - 3.80 |
Data in real-time, as of 4/24/2025 8:59:38 AM
3 Months Trend
Profile
Neimeth International pharmaceuticals plc engages in the manufacture and marketing of pharmaceutical, animal health, and general health care products in Nigeria. It offers consumer products, including analgesics, anthemintiasis, anti-stress/multivitamin, antimalarial/protozoal, antiseptic, and pediatric products; ethical products, which include anti-bacterial, anti-diabetic, anti-fungal, anti-hypertensive, anti-rheumatic, sedative, and sickle cell products; and veterinary products, which include anthelministics, antibiotics, and vitamins. The company offers its products in various forms, such as powders, capsules, syrups, tablets, and creams. It also offers contract manufacturing/analysis services. The company sells its products through distributors. Neimeth International pharmaceuticals plc was founded in 1957 and is headquartered in lkeja, Nigeria. Website: www.neimethplc.com Founded in: 1957
Quotes
| LClose | 2.78 | Price | 2.78 |
|---|---|---|---|
| Change | 0.00 (0.00%) | Low | 2.78 |
| High | 2.78 | EPS | 0.02 |
| 52WkHigh | 3.80 | 52WkLow | 1.51 |
| 50d Mov Avg | 2.93 | 200d Mov Avg | 2.35 |
| AvgDlyVol | 913.65K | 3MthChg | -0.32 (-10.32%) |
| 6MthChg | 0.88 (46.32%) | 12MthChg | 0.80 (40.40%) |
| Beta | 0.2543469 | Risk Factor | 0.00343514 |
| PE | 125.52 | Shares Outs. | 4.27B |
| Div. Yield | 3.38 | Market Cap | 11.88B |
| Volume | 45.42K | # Of Trades | 17 |
| Trades Value | 120.65K | ||
| Sector | Pharmaceuticals | ||
Income statement
Statement of Comprehensive Income as at
31-Mar-2018
| Name | Amount |
|---|---|
| Revenue | 2,269,004.00 |
| Profit before taxation | 202,479.00 |
| Taxation | 18,444.00 |
| Profit/(loss) after tax | 184,035.00 |
| Transfer to revenue reserve | 184,035.00 |
| Profit attributable to: | |
| Owners of the company | |
| Non-controlling interest | |
| Earnings per 50k share (k) | 11.00 |
| Net assets per 50k share (k) | 57.00 |
Board of directors
| Name | Title |
|---|---|
| Ambrose Orjiako | Non-Executive Chairman of the Board |
| Ebere Ekpunobi | Managing Director/Chief Executive Officer |
| Christopher Mmeje | Executive Director - Finance |
| Adekunle Adebowale | Manager |
| Isaac Igbanoi | Manager |
| Olufemi Ojakoya | Manager |
| Roseline Oputa | Manager |
| Florence Onyenekwe | Secretary |
| A. Balogun | Non-Executive Director |
| Maurice Iwu | Non-Executive Director |
| Godfrey Ohuabunwa | Non-Executive Director |
| Mazi Ohuabunwa | Non-Executive Director |
Currency
| Currency | Rate(₦) |
|---|---|
| USD USD/NGN | 1,606.20 |
| GBP GBP/NGN | 2,131.77 |
| EUR EUR/NGN | 1,823.19 |
| JPY JPY/NGN | 11.26 |
| CAD CAD/NGN | 1,159.85 |
| CNY CNY/NGN | 219.66 |
| AUD AUD/NGN | 1,024.10 |
| XOF XOF/NGN | 2.78 |
| XAF XAF/NGN | 2.78 |
| GHS GHS/NGN | 104.14 |
| AED AED/NGN | 437.30 |
| ZAR ZAR/NGN | 86.24 |
| JPY JPY/NGN | 11.26 |
| KES KES/NGN | 12.40 |
| EGP EGP/NGN | 31.47 |
| INR INR/NGN | 18.84 |
| AUD AUD/NGN | 1,024.10 |
| CHF CHF/NGN | 1,944.14 |
| DZD DZD/NGN | 12.12 |
| MAD MAD/NGN | 174.07 |
| AOA AOA/NGN | 1.75 |
| TZS TZS/NGN | 0.60 |
| BWP BWP/NGN | 117.58 |
| ETB ETB/NGN | 12.11 |
| NAD NAD/NGN | 86.08 |
| SDG SDG/NGN | 2.67 |
| MZN MZN/NGN | 25.10 |
| SLL SLL/NGN | 0.08 |
| MWK MWK/NGN | 0.93 |
| GMD GMD/NGN | 22.62 |
| BIF BIF/NGN | 0.54 |
| GNF GNF/NGN | 0.19 |
| LRD LRD/NGN | 8.05 |
| SZL SZL/NGN | 86.05 |
| CVE CVE/NGN | 16.66 |
| RWF RWF/NGN | 1.11 |
| DJF DJF/NGN | 9.03 |
| ERN ERN/NGN | 107.08 |
| ZMW ZMW/NGN | 56.41 |
